Pelvic Organ Prolapse Clinical Trial
Official title:
Catheter Management After Pelvic Reconstructive Surgery: a Randomized Controlled Trial
This is a randomized controlled trial comparing plug-unplug catheter management, continuous drainage catheter systems and patients that do not get discharged with catheters after inpatient pelvic reconstructive surgery.
This study will be a randomized controlled trial comparing plug-unplug (PUP) catheter
management, continuous drainage (CD) catheter systems and patients that do not get discharged
with catheters (reference) after pelvic reconstructive surgery. The primary objective of this
study is to assess impact on activity. The secondary objectives are to compare the rate of
urinary tract infection between the groups, duration of time (days) it takes for patients to
resume normal voiding, impact on post-operative pain and satisfaction with surgery experience
and post-operative recovery. The investigators hypothesize that patient activity/mobility one
week after surgery between the two methods of managing the transurethral catheter will be
different between arms. Subjects will be recruited at the Hartford Hospital Division of
Female Pelvic Medicine and Reconstructive Surgery during preoperative consultation for pelvic
reconstructive surgery with 1:1:1 assignment and randomization for PUP and CD groups only.
Prior to surgery, baseline activity will be assessed using the Activity Assessment Scale, as
well as postoperative expectations. Prior to hospital discharge, patients will undergo a
postoperative voiding trial (PVT) per regular clinical practice. Upon failure of PVT,
participants will be randomized 1:1 to one of two arms in which participants receive a
catheter: PUP or CD. The investigator responsible for data collection will remain blinded to
the treatment assignment throughout the study. Subjects who pass the PVT test and therefore
do not require a catheter will be assigned to the reference arm (Arm C). Subjects will be
followed after hospital discharge and assessed using the same pre- and post-operative
questionnaires as participants randomized to the CD and PUP arms and will comprise the first
32 consenting patients who do not require a catheter.
Subjects randomized to CD will have a 16F transurethral catheter attached to a leg bag and
receive teaching regarding home maintenance. Subjects randomized to PUP will have the same
16F transurethral catheter placed with a plastic plug and instructed to unplug and drain the
catheter when they feel the urge to void, or at least every four hours throughout the day.
Subjects in both groups will be provided a large bag for gravity-based drainage during the
night. Subjects also will be encouraged to call the research team with any catheter-related
questions or concerns including symptoms of urinary tract infection (UTI). Subjects with
symptoms of UTI (e.g., dysuria, urgency, frequency, and/or hematuria) will be evaluated and
treated per standard of care. All participants will then return for an office voiding trial
(OVT) five to seven days after hospital discharge, following the same protocol as the PVT. At
this time urinalysis will be obtained. Only those participants who endorse symptoms of UTI
will have a urine specimen collected and sent for culture. This is in line with the current
clinical practice by the investigators. Participants will be treated for UTI based on culture
results or if there is high clinical suspicion at the time of office follow-up. Participants
who fail the OVT will be discharged home with bladder drainage per standard of care and
undergo routine follow-up until they pass a repeat voiding trial.
The subjects will complete a post-operative questionnaire assessing pain, impact on activity
and satisfaction. Outcomes will be followed for up to six weeks after initial OVT if it is
failed; however, no additional research-associated visits will be necessary from study
participants beyond the initial office visit.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05420831 -
Comparison of Vaginal and Laparoscopic Apical Fixation Techniques for Pelvic Organ Prolapse Treatment
|
N/A | |
Active, not recruiting |
NCT05422209 -
The Influence of Simultaneous Posterior Colporrhaphy and Perineoplasty on the Efficiency and Safety of Mesh-augmented Sacrospinal Fixation (Apical Sling) in Advanced POP Repair.
|
N/A | |
Completed |
NCT05493735 -
Lidocaine for Pessary Check Pain Reduction
|
Phase 3 | |
Completed |
NCT06126328 -
Materna Prep Study Phase II
|
Phase 2 | |
Recruiting |
NCT05542836 -
EVeRLAST 2-Year Follow-Up
|
||
Recruiting |
NCT05918367 -
Multicenter Ventral Mesh Rectopexy Registry Collaborative
|
||
Recruiting |
NCT04172272 -
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
|
N/A | |
Recruiting |
NCT04807920 -
BOTOX® at the Time of Prolapse Surgery for OAB
|
Phase 4 | |
Completed |
NCT06268782 -
The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women
|
N/A | |
Recruiting |
NCT03146195 -
The 3D Reconstruction Research of Pelvic Organ Prolapse Disease
|
N/A | |
Recruiting |
NCT02919852 -
Laparoscopic Retrovesical Colpopectinopexia
|
N/A | |
Completed |
NCT02925585 -
Vaginal Tactile Imaging for Pelvic Floor Prolapse
|
||
Not yet recruiting |
NCT02536001 -
Prospective Randomized Study to Compare Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes
|
N/A | |
Recruiting |
NCT02113969 -
Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol
|
N/A | |
Completed |
NCT02383199 -
Polypropylene Mesh in Prolapse Surgery
|
N/A | |
Terminated |
NCT01673360 -
Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices
|
N/A | |
Withdrawn |
NCT01530191 -
Factors Affecting Perioperative Outcomes
|
N/A | |
Completed |
NCT01842464 -
Sacro-Spinous Ligaments Anterior Apical Anchoring
|
N/A | |
Completed |
NCT01320631 -
Male Sexual Experience and Its Impact on Quality of Life Before and After Their Sexual Partners Undergo Polypropylene Mesh Augmented Pelvic Floor Reconstruction
|
N/A | |
Completed |
NCT00581412 -
Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates
|
N/A |